Vol. 9, Issue 2, 182-188, February 1999
METHODS
Isolation of Human Transcripts Expressed in Hamster Cells from YACs by cDNA Representational Difference Analysis
Jessie
Gu,1,3
Xin-Yuan
Guan,2 and
Melissa A.
Ashlock1,4
1 Genetics and Molecular Biology Branch and
2 Cancer Genetics Branch, National Human Genome Research
Institute, National Institutes of Health,
Bethesda, Maryland 20892-4442 USA
Gene isolation methods used during positional cloning rely on
physical contigs consisting of bacterial artificial chromosomes, P1, or
cosmid clones. However, in most instances, the initial framework for
physical mapping consists of contigs of yeast artificial chromosome
(YACs), large vectors that are suboptimal substrates for gene
isolation. Here we report a strategy to identify gene sequences
contained within a YAC by using cDNA representational difference
analysis (RDA) to directly isolate transcripts expressed from the YAC
in mammalian cells. The RDA tester cDNAs were generated from a
previously reported hamster cell line derived by stable transfer of a
590-kb YAC (911D5) that expressed NPC1, the human gene responsible for Niemann-Pick type C (NP-C). The driver cDNAs were
generated from a control hamster cell line that did not contain the YAC
that expressed NPC1. Among the gene fragments obtained by RDA,
NPC1 was the most abundant product. In addition, two
non-NPC1 fragments were isolated that were mapped to and
expressed from 911D5. One of these RDA gene fragments (7-R)
spans more than one exon and has 98% sequence identity with a human
cDNA clone reported previously as an expressed sequence tag (EST), but
not mapped to a chromosomal region. The other fragment (2-R) that had
no significant sequence similarities with known mammalian genes or ESTs, was further localized to the region of overlap between YACs 911D5 and 844E3. The latter YAC is part of a contig
across the NP-C candidate region, but does not contain NPC1.
This two-part approach in which stable YAC transfer is followed by cDNA
RDA should be a useful adjunct strategy to expedite the cloning of human genes when a YAC contig is available across a candidate interval.
[The sequence data described in this paper have
been submitted to GenBank under accession nos. AF117641 and AF117642.]
3
Present address: Genome Therapeutics Corporation,
Department of Human Genetics, Waltham, Massachusetts 02154 USA.
4
Corresponding author.
9:182-188 ©1999 by Cold Spring Harbor Laboratory Press ISSN 1088-9051/99 $5.00